Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein (2022)

Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein. A. Sengupta, M. Azharuddin, M.E. Cardona, C. Devito, E. von Castelmur, A. Wehlin, Z. Pietras, M. Sunnerhagen, R. Selegård, D. Aili, A. Alamer, J. Hinkula, N. Al-Otaibi. Vaccines (2022) https://doi.org/10.3390/vaccines10040504